Literature DB >> 25922201

SIRT1-related inhibition of pro-inflammatory responses and oxidative stress are involved in the mechanism of nonspecific low back pain relief after exercise through modulation of Toll-like receptor 4.

Yuan-Yang Cheng1, Chung-Lan Kao2, Hsin-I Ma3, Ching-Hsia Hung4, Chin-Tien Wang5, Ding-Hao Liu2, Po-Yin Chen6, Kun-Ling Tsai7.   

Abstract

Low back pain is a common clinical problem that causes disability and impaired quality of life. While the reason behind low back pain was largely considered to be of musculoskeletal origin, the contribution of inflammatory cytokines and oxidative stress could never be overlooked. Exercise has been proven to be an effective approach to treat low back pain. However, the mechanism of the exercise effect on the inflammatory cytokines and oxidative stress is still largely unknown. In this study, we revealed that exercise intervention reduces Toll-like receptor 4 (TLR-4) pathway and enhances Sirtuin 1 (SIRT1) expression in low back pain patients. We also confirmed that exercise up-regulates the expression of peroxisome proliferator-activated receptor-gamma, PPAR-γ coactivator-1 and FoxOs family proteins and also increases the activity of catalase and superoxide dismutase in patients with low back pain. Furthermore, we found that exercise intervention attenuates the oxidative stress, pro-inflammatory cytokine concentrations and p53 expression in patients with low back pain. This study demonstrates that exercise intervention improves low back pain symptoms through regulation of the SIRT1 axis with repression of oxidative stress and TLR-4 inhibition.
© The Authors 2015. Published by Oxford University Press on behalf of the Japanese Biochemical Society. All rights reserved.

Entities:  

Keywords:  SIRT1; exercise; genes; low back pain; toll like receptor 4

Mesh:

Substances:

Year:  2015        PMID: 25922201     DOI: 10.1093/jb/mvv041

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  7 in total

1.  Evaluation of the effect of chiropractic manipulative treatment on oxidative stress in sacroiliac joint dysfunction.

Authors:  Turgut Kültür; Aydın Çiftçi; Müyesser Okumuş; Murat Doğan; Şenay Arıkan Durmaz; Salim Neşelioğlu; Özcan Erel
Journal:  Turk J Phys Med Rehabil       Date:  2020-05-18

Review 2.  Aerobic but not Resistance Exercise Can Induce Inflammatory Pathways via Toll-Like 2 and 4: a Systematic Review.

Authors:  Paula Andréa Malveira Cavalcante; Marcos Fernandes Gregnani; Jessica Salles Henrique; Fábio Henrique Ornellas; Ronaldo Carvalho Araújo
Journal:  Sports Med Open       Date:  2017-11-28

3.  MicroRNA‑217 is involved in the progression of atherosclerosis through regulating inflammatory responses by targeting sirtuin 1.

Authors:  Liyun Zhang; Juan Chen; Qin He; Ze Chao; Xuyong Li; Manhua Chen
Journal:  Mol Med Rep       Date:  2019-08-09       Impact factor: 2.952

4.  MicroRNA‑217 inhibition relieves cerebral ischemia/reperfusion injury by targeting SIRT1.

Authors:  Gaofeng Rao; Wenfu Zhang; Shegeng Song
Journal:  Mol Med Rep       Date:  2019-05-31       Impact factor: 2.952

Review 5.  Genes and Longevity of Lifespan.

Authors:  May Nasser Bin-Jumah; Muhammad Shahid Nadeem; Sadaf Jamal Gilani; Fahad A Al-Abbasi; Inam Ullah; Sami I Alzarea; Mohammed M Ghoneim; Sultan Alshehri; Aziz Uddin; Bibi Nazia Murtaza; Imran Kazmi
Journal:  Int J Mol Sci       Date:  2022-01-28       Impact factor: 5.923

6.  Presence of Tumor Necrosis Factor-Alpha in Urine Samples of Patients With Chronic Low Back Pain Undergoing Chiropractic Care: Preliminary Findings From a Prospective Cohort Study.

Authors:  Carlos Gevers-Montoro; Mar Romero-Santiago; Lisa Losapio; Francisco Miguel Conesa-Buendía; Dave Newell; Luis Álvarez-Galovich; Mathieu Piché; Arantxa Ortega-De Mues
Journal:  Front Integr Neurosci       Date:  2022-04-12

Review 7.  The Crosstalk between the Gut Microbiota and Mitochondria during Exercise.

Authors:  Allison Clark; Núria Mach
Journal:  Front Physiol       Date:  2017-05-19       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.